Medicare coverage for certain diabetes and obesity treatments is being reported on, with some outlets discussing what is and isn't covered. The coverage of specific medications, such as GLP-1s, is a focus of the reports, with some indicating that there may be temporary programs or limitations on coverage. The specifics of what is covered and how to access affordable treatments appear to be complex and potentially subject to change.